Registered vaccinations according to the electronic vaccination system
persons (% of the vaccinable population) have received a first dose of a COVID-19 vaccine.
persons (%) have received the doses necessary for complete immunisation.
On average every seconds a vaccination dose is administered in Austria. Statistically, since you first accessed this site, received a dose.
Calculated on the basis of the registered vaccinations of the last seven days (mean value over 24 hours)
First COVID-19 vaccine (BioNTech/Pfizer) is authorised for use throughout the EU
The first COVID-19 vaccination in Austria takes place
since January 2021
People over the age of 80, those in nursing homes and category 1 health care personnel are being vaccinated
Moderna vaccine is authorised for use throughout the EU
100,000 people have been vaccinated against COVID-19
AstraZeneca vaccine is authorised for use throughout the EU
High-risk patients, people with disabilities, their personal assistants, as well as category 2 health care personnel are being vaccinated
Austria orders six million additional doses of vaccine
500,000 people have been vaccinated against COVID-19
People aged 65 – 79 as well as contact persons of pregnant women and category 3 and 4 health care personnel will be vaccinated
Staff and personnel in schools, nursery schools, prisons, the police and the armed forces will be vaccinated
The entire population will be vaccinated, with priority for older people and those at higher risk
Provisional information. Subject to changes. Definition of the target groups is simplified to aid comprehensibility.
Vaccination rate Total population
The vaccine-eligible population (over 16 years of age) is currently 7,757,564 people or 87% of the total population.
Vaccination rate by age and gender
first / second dose
% () first dose Women 85+
% () second dose Women 85+
% () first dose Men 85+
% () second dose Men 85+
first dose Non-binary 85+
second dose Non-binary 85+
Austrian COVID-19 vaccination map
Selecting a federal state displays the current vaccination numbers.
471.510 in März
789.750 in April
123.600 in März
115.200 in April
COVID-19 Vaccine Moderna
350.000 in März
COVID-19 Vaccine AstraZeneca
Janssen Johnson & Johnson
Market authorization expected towards the end of Q1/2021
Market authorization expected in Q2/2021
Market authorization expected in 2022
Subject to modifications by manufacturer and market authorization. Based on the current status and assuming that market authorization and deliveries for all manufacturers occur as scheduled, a total of approximately 30 million vaccine doses will be available by the end of 2021.